Autologous bone marrow harvesting in outpatients

Area of Science:

• Oncology
• Hematology
• Ambulatory Surgery

Background:

• Autologous bone marrow harvesting is a critical procedure in various cancer treatments.
• Evaluating the feasibility and outcomes of performing this procedure in an outpatient setting is essential for optimizing patient care and resource utilization.

Purpose of the Study:

• To evaluate the safety, efficacy, and patient experience of autologous bone marrow harvesting in an outpatient setting.
• To compare the outcomes, complications, and costs of outpatient versus inpatient bone marrow harvesting.

Main Methods:

• Retrospective analysis of 235 outpatients undergoing 264 autologous bone marrow harvests between 1990 and 1992.
• Patients selected had Karnofsky performance status of 80-100 and ASA status I, II, or III.
• Data collected included perioperative complications, hospital admissions, procedure duration, postanesthesia care unit (PACU) stay, pain management, costs, and charges.

Main Results:

• Only 1.1% of harvests required hospital admission, with low rates of postanesthesia complications such as hypotension, dizziness, nausea, and vomiting.
• Postoperative pain was generally well-controlled, with 72.9% of patients not requiring prescribed opioid medication at home.
• Outpatient harvesting resulted in significant cost savings (51.1% of inpatient charges) and time efficiencies.

Conclusions:

• Autologous bone marrow harvesting is a safe and acceptable ambulatory surgical procedure.
• The outpatient setting is associated with a low postanesthesia complication rate and easily managed postoperative pain.
• Ambulatory bone marrow harvesting provides significant cost and time advantages for patients.